Literature DB >> 7294094

Pseudomonas corneoscleral ulcers.

I M Raber, P R Laibson, G H Kurz, V B Bernardino.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 7294094     DOI: 10.1016/0002-9394(81)90524-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  8 in total

1.  Clinical experiences of infectious scleral ulceration: a complication of pterygium operation.

Authors:  C P Lin; M H Shih; M C Tsai
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

2.  Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.

Authors:  R W Darrell; S M Modak; C L Fox
Journal:  Trans Am Ophthalmol Soc       Date:  1984

3.  Bacterial keratitis in the critically ill.

Authors:  B Parkin; A Turner; E Moore; S Cook
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

4.  Intrascleral dissemination of infectious scleritis following pterygium excision.

Authors:  C H Hsiao; J J Chen; S C Huang; H K Ma; P Y Chen; R J Tsai
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

5.  Infectious scleritis: report of four cases.

Authors:  M Sainz de la Maza; R K Hemady; C S Foster
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

6.  Clinico-microbiological profile and treatment outcome of infectious scleritis: experience from a tertiary eye care center of India.

Authors:  Srikant Kumar Sahu; Sujata Das; Savitri Sharma; Kalyani Sahu
Journal:  Int J Inflam       Date:  2011-11-20

7.  Nocardia scleritis-clinical presentation and management: a report of three cases and review of literature.

Authors:  Srikant Kumar Sahu; Savitri Sharma; Sujata Das
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-10-08

8.  Outcomes of evisceration or enucleation by resident trainees in patients with recalcitrant endophthalmitis or panophthalmitis.

Authors:  Wannaporn Tianthong; Orapan Aryasit
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.